| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |